0000899243-20-029327.txt : 20201027
0000899243-20-029327.hdr.sgml : 20201027
20201027173116
ACCESSION NUMBER: 0000899243-20-029327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201027
FILED AS OF DATE: 20201027
DATE AS OF CHANGE: 20201027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VINK PATRICK V.J.J.
CENTRAL INDEX KEY: 0001557501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38266
FILM NUMBER: 201265270
MAIL ADDRESS:
STREET 1: ETZELSTRASSE 20
CITY: 8707 UETIKON AM SEE
STATE: V8
ZIP: V8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701108
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-242-1600
MAIL ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Spero Therapeutics, LLC
DATE OF NAME CHANGE: 20170316
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-27
0
0001701108
Spero Therapeutics, Inc.
SPRO
0001557501
VINK PATRICK V.J.J.
C/O SPERO THERAPEUTICS, INC.
675 MASSACHUSETTS AVENUE, 14TH FLOOR
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
13.52
2020-10-27
4
A
0
7500
0.00
A
2030-10-27
Common Stock
7500
7500
D
The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date.
/s/ Patrick V.J.J. Vink
2020-10-27